Evidence map›Paper›PMID 38364098›Full record

ArticleMicrobiology spectrum2024

Evaluation of CHROMagar

Meghan L Bentz, Ngoc Le, Brian Min, Natalie S Nunnally, Vickie Sullivan, Mike Tran, Shawn R Lockhart, Ana Litvintseva, Elizabeth L Berkow, D Joseph Sexton

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Animals : an open access journal from MDPI · 2025
    Review
  3. Article
  4. Consensus paper onTurkish journal of medical sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Meghan L BentzMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0001-9432-5858
Ngoc LeMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Brian MinMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Natalie S NunnallyMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Vickie SullivanMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Mike TranWashington State Department of Health, State Public Health Agency, Shoreline, Washington, USA.
Shawn R LockhartMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0002-4383-5994
Ana LitvintsevaMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0003-1086-8041
Elizabeth L BerkowMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
D Joseph SextonMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0003-3099-7334

Funding

HHS | CDC | National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
6 · The paper itself

Abstract

CHROMagar

Indexed as

CandidaCandidiasisAntifungal AgentsCandida aurisColoring AgentsCulture MediaHumansAntifungal AgentsColoring AgentsCulture MediaCandida aurisCHROMagarcolonization screeningculturediagnosticsfungi

Identifiers

PMID38364098
PMCPMC10986463

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.